Pfizer Uses Layered Knowledge Management To Guide Tech Transfers
Executive Summary
Pfizer has developed a multilayered knowledge management program that aims to ease the tech transfer process by harnessing institutional knowledge into one place. The program allows employees to ensure that processes remain stable during tech transfer by exploring all available process knowledge available on the product.
You may also be interested in...
US FDA Developing Database Of Medical Review Decisions, Gottlieb Tells Congress
'Knowledge management platform' will identify agency's scientific precedents; Commissioner Gottlieb says it is one of FDA's top three initiatives, along with continuous manufacturing and real-time safety monitoring.
European Notebook: Industry’s Post-EU Election Goals; IMI2 Gets Under Way; FDA/EMA Tie-Up On Childhood Gaucher Studies
Worries about science bases drew European politicians to the AstraZeneca/Pfizer merger debate; the European industry calls for EU-wide R&D agenda, standards of care; IMI2 public-private partnership gets under way; FDA and EMA to collaborate on clinical trials for childhood Gaucher disease.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”